pharma · Hematologic Malignancies · Solid Tumor, Adult
Farmatek
Zafatek
Farmatek is a pharma organization headquartered in Istanbul, JP. Primary therapeutic focus areas include Hematologic Malignancies, Solid Tumor, Adult, Lymphoma, B-Cell, B-cell Mediated Autoimmune Diseases, COPD. NovaPhar
Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP HQ
1994 Founded
14 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP
- Founded
- 1994
- Employees
- 14
- Programs
- 26
- Drugs
- 14
- Patents
- 53
Single FT1050 treated UCB unit
Phase 1 · mab · Non-Hodgkin's Lymphoma (NHL)
Single FT1050 treated UCB unit for Non-Hodgkin's Lymphoma (NHL) is a Phase 1 program (mab) at Zafatek with 1 ClinicalTrials.gov record(s).
Internal code FT1050-02
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Zafatek
- Phase
- Phase 1
- Modality
- mab
- Indication
- Non-Hodgkin's Lymphoma (NHL)
- Status
- completed
- Trials
- 1